Post-ASH Meeting – Significant Highlights 6 CPD Points RCPath Thursday 15th January 2015 Brunei Lecture Theatre, School of Oriental and African Studies, Thornhaugh Street, Russell Square, London Chair: Dr Robert Marcus, King’s College Hospital, London Co-Chair: Professor David Linch, University College London 08:30 Registration Session 1: 09:00 09:40 Next generation sequencing – implications for diagnosis and therapy Dr Brian Huntly New inhibitors of thrombosis – is warfarin obsolete? Professor Roopen Arya University of Cambridge King’s College Hospital, London 10:20 Novel agents in acute lymphoblastic leukaemia Dr Adele Fielding University College London 10:40 Targeted therapies for AML 11:10 Coffee Professor Nigel Russell Nottingham University Hospitals Session 2: 11:30 12:15 13:00 Advances in multiple myeloma - the end of stem cell transplantation? Professor Kwee Yong Low grade lymphoproliferative disorders - the role of signal transduction inhibitors Professor Stephen Devereux University College London King’s College Hospital, London Lunch Session 3: 13:45 Aggressive lymphoma – is there any progress? Dr Graham Collins Oxford University Hospitals 14:30 15:15 15:55 Myeloproliferative disorders - Jak2 and other inhibitors Professor Claire Harrison Aplastic anaemia and other bone marrow failure syndromes Professor Ghulam Mufti Guy’s and St Thomas’ NHS Trust, London King’s College London Coffee Session 4: 16:15 Haemoglobinopathy update 17:00 Feedback 17:30 Close Professor David Rees King’s College Hospital, London Registration Fees: Early Bird offer until 6 November 2014: £75 Consultants / £60 Trainees & others From 7th November 2014: £100 for everyone th Register online at www.hartleytaylor.co.uk For further information, please contact [email protected] or telephone 01565 621967 Meeting endorsed by British Society for Haematology
© Copyright 2024 ExpyDoc
